Skip to main content
IDCases logoLink to IDCases
. 2017 Jun 15;9:56–58. doi: 10.1016/j.idcr.2017.06.004

New Delhi metallo-β-lactamase-1 (NDM-1) Escherichia coli isolated from household vacuum cleaner—Oregon, 2013

Genevieve L Buser a,, P Maureen Cassidy a, Christopher D Pfeiffer b,c, John M Townes c, Karim E Morey d, Jaipreet Rayar e, Kirthi K Kutumbaka f, Sukkyun Han f, Cesar Nadala f, Mansour Samadpour f, Scott J Weissman e, Robert Vega d, Zintars G Beldavs a
PMCID: PMC5484987  PMID: 28660132

Abstract

The first Oregon case of New Delhi metallo-β-lactamase-1 (NDM-1)-producing Escherichia coli was reported during November 2013. Epidemiologic investigation revealed only local outpatient medical care and no travel outside Oregon for both the patient and his household contact. Environmental sampling discovered a matching isolate from the patient’s household vacuum cleaner, suggesting environmental persistence.

Keywords: Escherichia coli, NDM-1-beta-lactamase, Environmental microbiology, Plasmids, Vacuum cleaner

Introduction

Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) facilitate the spread of broad-spectrum antibiotic resistance around the globe via transferable plasmids. New Delhi metallo-β-lactamase-1 (NDM-1)-producers are increasingly reported; however, they remain rare in the northwest US [1]. The NDM-1-carrying plasmid is commonly associated with Escherichia coli, but is found in Klebsiella, Pseudomonas, Acinetobacter, and Salmonella [2]. The vast majority of NDM-1 reports are associated with returning travelers or healthcare from endemic areas; however, uncommonly these exposures are not identified [3], [4]. Little is known about where the isolate might persist in non-endemic areas. During November 2013, Oregon identified its first reported NDM-1-producing E. coli via mandated laboratory CRE surveillance.

Methods

Oregon began statewide CRE surveillance during December 2011, after establishing the Drug Resistant Organism Prevention and Coordinated Regional Epidemiology (DROP-CRE) network [5]. At the time this case was identified, CRE were defined as Enterobacteriaceae isolates non-susceptible to ≥1 carbapenem and non-susceptible to any tested third-generation cephalosporins. Isolates meeting the case definition were submitted by laboratories to the Oregon State Public Health Laboratory (OSPHL) for phenotypic screening (e.g., modified Hodge test, Carba NP test), followed by genotypic testing [6], [7], [8]. By November 2013, DROP-CRE had identified 137 CRE cases; of these, 2 were KPC-producing Klebsiella pneumoniae. Per CP-CRE protocol, we investigated to determine potential risk factors, identify the source, and prevent transmission.

Because initial review of the NDM case did not reveal traditional risk exposures, we launched a more in depth investigation. The investigation included laboratory and chart reviews, case and healthcare provider interviews, healthcare and household contact screenings, site visits, and, when indicated, environmental testing. Additionally, molecular typing, whole genome sequencing, and environmental testing were performed [9]. All samples were collected from the original containers or the vacuum bag, placed into a sterile Whirl-Pak®, and submitted directly for extraction and testing.

Results

Case investigation

A shin wound culture taken in the outpatient setting from a rural Oregon Caucasian resident yielded an NDM-1 positive, extended-spectrum β-lactamase (ESBL) CTX-M-27-producing E. coli O25b-ST131 isolate with a IncF plasmid of type F29:A2:B10 [9]. Antimicrobial susceptibility Microscan® results for the E. coli isolate are summarized below (Table 1).

Table 1.

Minimum inhibitory concentrations (MIC) for an isolate of NDM-producing Escherichia coli— Oregon, 2013.

Minimum inhibitory concentrations (MIC) for NDM-producing Escherichia coli— Oregon, 2013
Antibiotica A/S PT CTX CEP IMI MER GEN CIP COL PB
MIC (μg/mL) >16/8 >64 >32 >16 >8 >8 2 >2 0.5 0.5
Interpretation R R R R R R S R NA NA
a

A/S = ampicillin/sulbactam, PT = Piperacillin/tazobactam, CTX = ceftriaxone, CEP = cefepime, IMI = imipenem, MER = meropenem, GEN = gentamicin, CIP = ciprofloxacin, COL = colistin, PB = polymixin B.

The patient had injured his lower leg at home; cellulitis ensued despite self-treatment with an expired triple-antibiotic cream. The wound culture grew 1+ Gram-negative bacilli, identified as NDM-1-producing E. coli, and 4+ methicillin-sensitive Staphylococcus aureus, presumed to be the causative organism, as the case improved with oral clindamycin. The patient and spouse denied international or interstate travel, international visitors or international travel among close contacts, foreign healthcare providers, and direct contact with domestic or wild animals. They denied hospitalizations or medical procedures in the previous 12 months; we confirmed only local, outpatient clinic visits during the previous year. They reported purchasing nutritional supplements on the internet, and ate seafood at a local Thai restaurant. Wild deer, elk, and turkey roamed their forested property. Cattle grazed one-half mile away. Review of regional laboratory reports did not identify other NDM-positive CRE during the preceding year, even for laboratory certification purposes. CRE surveillance rectal swabs collected from the case (n = 3) at 3, 5, and 7.5 weeks after the index isolate, and from the spouse (n = 1) at 15 weeks, were negative. Given the lack of an obvious NDM source, we considered outpatient clinic specimen contamination or laboratory error, unusual exposures such as food or spice contamination, wild animal feces, and household water system contamination.

Environmental testing

Spice (n = 14), nutritional supplement (n = 15), indoor environmental (n = 13), outdoor environmental (n = 18), and vacuum dust (n = 4) samples were collected two months after index culture. An NDM-1-producing E. coli isolate indistinguishable by PFGE from the patient’s isolate was extracted and cultured from a household vacuum bag dust sample. The case reported vacuuming indoors weekly. The clinical and household vacuum isolates were found to be homogeneous by DNA-DNA hybridization (value 99.3% ± homogeneity) [9] (Fig. 1).

Fig. 1.

Fig. 1

Pulsed-field gel electrophoresis profiles of case NDM-1-producing E. coli isolate and household vacuum bag dust sample obtained two months after the index clinical culture.

Discussion

NDM-1-producing CRE are rare in the U.S.; since 2009, only 157 cases had been reported at the time of our investigation. Previously reported NDM-1-producing CRE have been associated with healthcare, travel to endemic areas, and spontaneous acquisition [1]. While we were unable to identify a single source of NDM-1 producing E. coli, recovery of a matching strain from a vacuum cleaner likely excludes a false identification, and raises the concern about the persistence of pathogenic strains in the environment.

After excluding typical risk factors for CRE colonization or a pseudo-source (e.g., laboratory contamination), we pursued alternatives based upon exposure history, including foodstuffs. Spices, including red and black pepper, can support the growth of some bacteria, and have been the source of previous outbreaks [10], [11]. Similarly, nutritional supplement manufacturing is not regulated, and investigation of the brands used by the case revealed that components were sourced from China, Malaysia, and India (PMC, communications with manufacturer). Although spices and nutritional supplements were suspected, carbapenem-resistant E. coliwere not isolated from these sources [9]. Seafood has been associated with multidrug-resistant Gram-negative isolates, and is commonly processed in Asia, even after harvest in US waters [12]. This risk may derive from contaminated environmental water sources [13], [14].

Whatever the initial source of acquisition, the patient likely contaminated his environment with a CRE, which persisted even two months after the initial wound isolation. Pathogens (e.g., E. coli O157:H7 [15], Salmonella spp. [16]) can survive for extended periods in common household vacuum cleaners [17], [18]. As suggested by this investigation, CRE can persist in the environment in protected niches for extended periods of time.

The Oregon clone has unique epidemiologic and molecular characteristics. NDM-1 is usually associated with global E. coli clones (e.g., sequence types 405 and 101). However, this E. coli belongs to ST131, a globally emergent pathogenic clone that accounts for approximately two-thirds of ESBL-producing E. coli in the US. The ESBL phenotype of these strains is typically a result of plasmid-mediated blaCTX-M-15 carriage by a distinctive ST131 clade known as C2/H30Rx [19]. However, ST131 carriage of blaCTX-M-27 is now increasingly being described, with cases now reported from Japan, Korea, China, Australia, Nepal, Cambodia, Israel, Czech Republic, Switzerland, Spain, France, Portugal, Netherlands, Canada, and the United States [20]. A recent analysis by Matsumura et al. of 21 blaCTX-M-27-bearing ST131 isolates from Japan (n = 13), Australia (n = 3), US (n = 2, including our patient), Canada (n = 1), Thailand (n = 1), and Vietnam (n = 1) suggested that this unique clade (known as C1-M27) emerged from the larger C1/H30R clade of ST131 in Japan during the late 2000 s [20]. In addition, our E. coli carried an IncF plasmid of type F29:A2:B10, which was common among the international isolates of C1-M27 strains [21], [22], [23], [24]. Given these observations, we suspect that a ST131 strain of the C1-M27 clade, carrying blaCTX-M-27 on an F29:A2:B10 plasmid, acquired NDM on a separate plasmid backbone, such as IncN2.

Conclusions

We report a patient with domestically acquired NDM-1-carrying E. coli strain carrying a suspected East Asian or Australian plasmid presumably acquired through non-healthcare exposures. As our knowledge and experience of CP-CRE expand, we recommend during investigation to inquire about travel exposures and imported food that can transport multidrug-resistant organisms from endemic to non-endemic regions worldwide [25]. Broadened hypothesis generation as part of the case investigation might include relevant foodstuffs processed in countries with endemic CP-CRE. Libraries of molecular strain characterizations supplemented with detailed epidemiologic data could permit trace-back to sources, as is done in foodborne outbreak investigations.

Funding

G.L.B., P.M.C, R.V., C.D.P., Z.G.B.: This work was funded by the Epidemiology and Laboratory Capacity cooperative agreement numberNU50CK000484-01-01 with the Centers for Disease Control and Prevention. The authors report no conflicts of interest between themselves and this manuscript.

References

  • 1.Rasheed J.K., Kitchel B., Zhu W., Anderson K.F., Clark N.C., Ferraro M.J. Metallo-β-lactamase–producing Enterobacteriaceae, United States. Emerg Infect Dis. 2013;19:870–878. doi: 10.3201/eid1906.121515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yong D., Toleman M.A., Giske C.G., Cho H.S., Sundman K., Lee K. Characterization of a new metallo-beta-lactamase gene, bla (NDM), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumonia sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–5054. doi: 10.1128/AAC.00774-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.CDC Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients — Rhode Island, March 2012. MMWR. 2012;61:446–448. [PubMed] [Google Scholar]
  • 4.CDC Notes from the field: New Delhi metallo-beta-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography—Illinois, 2013. MMWR. 2014;62:1051. [PMC free article] [PubMed] [Google Scholar]
  • 5.Pfeiffer C.D., Cunningham M.C., Poissant T., Furuno J.P., Townes J.M., Leitz A. Establishment of a statewide network for carbapenem-resistant Enterobacteriaceae prevention in a low-Incidence region. Infect Contr Hosp Epidemiol. 2014;35:356–361. doi: 10.1086/675605. [DOI] [PubMed] [Google Scholar]
  • 6.Morey K.E., Vega R., Cassidy P.M., Buser G.L., Rayar J.K., Myers J.A. Evaluation of the carba NP test in oregon, 2013. Antimicrob Agents Chemother. 2017;61:e03005–15. doi: 10.1128/AAC.03005-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.CDC . 2017. Laboratory Protocol for Detection of Carbapenem-Resistant or Carbapenemase-Producing, Klebsiella spp. and E. coli from Rectal Swabs, December 2008. https://www.cdc.gov/hai/pdfs/labsettings/klebsiella_or_ecoli.pdf. Accessed 26 December 2016. [Google Scholar]
  • 8.Nordmann P., Poirel L., Dortet L. Rapid detection of carbapenemase-producing enterobacteriaceae. Emerg Infect Dis. 2012;18:1503. doi: 10.3201/eid1809.120355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kutumbaka K.K., Han S., Mategko J., Nadala C., Buser G.L., Cassidy P.M. Draft genome sequence of blaNDM-1-positive Escherichia coli O25b-ST131 clone isolated from an environmental sample. Genome Announc. 2014;2:e00462–14. doi: 10.1128/genomeA.00462-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.CDC Salmonella montevideo infections associated with salami products made with contaminated imported black and red pepper—United State, july 2009–april 2010. MMWR. 2010;59:1647–1650. [PubMed] [Google Scholar]
  • 11.Keller S.E., VanDoren J.M., Grasso E.M., Halik L.A. Growth and survival of Salmonella in ground black pepper (Piper nigrum) Food Microbiol. 2013:182–188. doi: 10.1016/j.fm.2012.12.002. [DOI] [PubMed] [Google Scholar]
  • 12.Rubin J.E., Ekanayake S., Fernando C. Carbapenemase-producing organism in food, 2014. Emerg Infect Dis. 2014;20:1264–1265. doi: 10.3201/eid2007.140534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Walsh T.R., Weeks G., Livermore D.M., Toleman M.A. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet. 2011;11:355–362. doi: 10.1016/S1473-3099(11)70059-7. [DOI] [PubMed] [Google Scholar]
  • 14.Isozumi R., Yoshimatsu K., Yamashiro T., Hasebe F., Nguyen B.M., Ngo T.C. blaNDM-1-positive Klebsiella pneumoniae from environment, Vietnam. Emerg Infect Dis. 2012;18:1383–1384. doi: 10.3201/eid1808.111816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Haysom I.W., Sharp K. The survival and recovery of bacteria in vacuum cleaner dust. J R Soc Prom Health. 2003;123:39–45. doi: 10.1177/146642400312300114. [DOI] [PubMed] [Google Scholar]
  • 16.Valerio C.R., Murray P., Arlian L.G., Slater J.E. Bacterial 16S ribosomal DNA in house dust mite cultures. J Allergy Clin Immunol. 2005;116:1296–1300. doi: 10.1016/j.jaci.2005.09.046. [DOI] [PubMed] [Google Scholar]
  • 17.Rice D.H., Hancock D.D., Roozen P.M., Szymanski M.H., Scheenstra B.C., Cady K.M. Household contamination with Salmonella enterica. Emerg Infect Dis. 2003;9:120–121. doi: 10.3201/eid0901.020214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Laidler M., Tourdjman M., Buser G., Hostetler T., Repp K., Leman R.F. Escherichia coli O157:H7 infections associated with consumption of locally grown strawberries contaminated by deer. Clin Infect Dis. 2013;57:1129–1134. doi: 10.1093/cid/cit468. [DOI] [PubMed] [Google Scholar]
  • 19.Stoesser N., Sheppart A.E., Pankhurst L., De Maio N., Moore C.E., Sebra R. Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. MBio. 2016;7:e02162. doi: 10.1128/mBio.02162-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Matsumura Y., Pitout J.D.D., Gomi R., Matsuda T., Noguchi T., Yamamoto M. Global Escherichia coli sequence type 131 clade with bla-CTX-M-27 gene. Emerg Infect Dis. 2016;22:1900–1907. doi: 10.3201/eid2211.160519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Netikul T., Sidjabat H.E., Paterson D.L., Kamolvit W., Tantisiriwat W., Steen J.A. Characterization of an IncN2-type blaNDM-1-carrying plasmid in Escherichia coli ST131 and Klebsiella pneumonia ST11 and ST15 isolates in Thailand. J Antimicrob Chemother. 2014;69:3161–3163. doi: 10.1093/jac/dku275. [DOI] [PubMed] [Google Scholar]
  • 22.McGann P., Snesrud E., Ong A.C., Appalla L., Koren M., Kwak Y.I. War wound treatment complications due to transfer of an IncN plasmid harboring blaOXA-181 from Morganella morganii to CTX-M-27-Producing sequence type 131 Escherchia coli. Antimicrob Agents Chemother. 2015;59:3556–3562. doi: 10.1128/AAC.04442-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chen C.J., Wu T.L., Lu P.L., Chen Y.T., Fung C.P., Chuang Y.C. Closely related NDM-1-encoding plasmids from Escherichia coli and Klebsiella pneumonia in Taiwan. PLoS One. 2014;9:e104899. doi: 10.1371/journal.pone.0104899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chen C.J., Wu T.L., Lu P.L., Chen Y.T., Fung C.P., Chuang Y.C. Closely related NDM-1-encoding plasmids from Escherichia coli and Klebsiella pneumonia in Taiwan. PLoS One. 2014;9:e104899. doi: 10.1371/journal.pone.0104899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Janelle S.J., Kallen A., de Man T., Limbago B., Walters M., Halpin A. Notes from the field: New Delhi metallo-β-lactamase–producing carbapenem-resistant enterobacteriaceae identified in patients without known health care risk factors—Colorado, 2014–2016. MMWR Morb Mortal Wkly Rep. 2016;65:1414–1415. doi: 10.15585/mmwr.mm6549a6. [DOI] [PubMed] [Google Scholar]

Articles from IDCases are provided here courtesy of Elsevier

RESOURCES